Literature DB >> 3994941

Long-term outcome of primary acute angle-closure glaucoma.

R David, Z Tessler, Y Yassur.   

Abstract

Factors influencing the long-term cure of 116 consecutive cases of acute angle-closure glaucoma, with at least one year's follow-up were examined. Delay in presentation and the time needed to terminate the attack were found to have a detrimental effect on the final outcome, while the height of the intraocular pressure at the time of the attack was found to be unimportant in predicting the long-term prognosis of the disease.

Entities:  

Mesh:

Year:  1985        PMID: 3994941      PMCID: PMC1040578          DOI: 10.1136/bjo.69.4.261

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  4 in total

1.  Peripheral iridectomy in closed angle glaucoma-- late complications.

Authors:  N Floman; D Berson; L Landau
Journal:  Br J Ophthalmol       Date:  1977-02       Impact factor: 4.638

2.  Management of acute primary angle-closure glaucoma: a long-term follow-up of the results of peripheral iridectomy used as an initial procedure.

Authors:  T J Playfair; P G Watson
Journal:  Br J Ophthalmol       Date:  1979-01       Impact factor: 4.638

3.  The long-term effects of iridectomy for primary acute angle-closure glaucoma.

Authors:  T Krupin; K B Mitchell; M F Johnson; B Becker
Journal:  Am J Ophthalmol       Date:  1978-10       Impact factor: 5.258

4.  Acute closed-angle glaucoma: an investigation into the effect of delay in treatment.

Authors:  J S Hillman
Journal:  Br J Ophthalmol       Date:  1979-12       Impact factor: 4.638

  4 in total
  14 in total

1.  Does the pilocarpine phenylephrine provocative test help in the management of acute and subacute angle closure glaucoma?

Authors:  P K Wishart
Journal:  Br J Ophthalmol       Date:  1991-05       Impact factor: 4.638

2.  Anterior chamber paracentesis in patients with acute elevation of intraocular pressure.

Authors:  Stéphane Arnavielle; Catherine Creuzot-Garcher; Alain M Bron
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-11-17       Impact factor: 3.117

3.  Anterior chamber paracentesis and pH values in patients with acute primary angle closure.

Authors:  Da-Wen Lu; Ming-Cheng Tai; Yun-Hsiang Chang; Chang-Min Liang; Ching-Long Chen; Ke-Hung Chien; Jiann-Torng Chen; Yi-Hao Chen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-11-11       Impact factor: 3.117

4.  Efficacy and safety of intravenous injection of lidocaine in the treatment of acute primary angle-closure glaucoma: a pilot study.

Authors:  Xiuming Jin; Anquan Xue; Yune Zhao; Qin Qin; Xiang-Da Eric Dong; Jia Qu
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-04-17       Impact factor: 3.117

5.  Can the pilocarpine phenylephrine provocative test be used to detect covert angle closure?

Authors:  P K Wishart
Journal:  Br J Ophthalmol       Date:  1991-10       Impact factor: 4.638

6.  Pentacam changes in primary angle-closure glaucoma after different lines of treatment.

Authors:  Tharwat H Mokbel; Abd-Elmonem Elhesy; Ahmed Alnagdy; Mohammed F Elashri; Ahmed M Eissa; Walid M Gaafar; Sherein M Hagras
Journal:  Int J Ophthalmol       Date:  2020-04-18       Impact factor: 1.779

7.  Acute angle closure glaucoma: relative failure of YAG iridotomy in affected eyes and factors influencing outcome.

Authors:  S A Buckley; B Reeves; M Burdon; C Moorman; S Wheatcroft; C Edelsten; L Benjamin
Journal:  Br J Ophthalmol       Date:  1994-07       Impact factor: 4.638

8.  Conventional and emerging treatments in the management of acute primary angle closure.

Authors:  Pui Yi Boey; Shweta Singhal; Shamira A Perera; Tin Aung
Journal:  Clin Ophthalmol       Date:  2012-03-15

9.  FLASH: A Novel Tool to Identify Vision-Threating Eye Emergencies.

Authors:  Neil Jairath; Patrick Commiskey; Ariane Kaplan; Yannis M Paulus
Journal:  Int J Ophthalmic Res       Date:  2020-10-08

10.  Long-term outcomes after acute primary angle closure in a White Caucasian population.

Authors:  Walter Andreatta; Ibrahim Elaroud; Peter Nightingale; Maged Nessim
Journal:  BMC Ophthalmol       Date:  2015-08-19       Impact factor: 2.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.